LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹581 Cr | ₹510 Cr | ₹472 Cr | ₹424 Cr | ₹386 Cr |
What is the latest Revenue of LINCOLN PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹581 Cr |
| Mar2024 | ₹510 Cr |
| Mar2023 | ₹472 Cr |
| Mar2022 | ₹424 Cr |
| Mar2021 | ₹386 Cr |
How is Revenue of LINCOLN PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹581 Cr | 13.76 | |
| Mar2024 | ₹510 Cr | 8.09 | |
| Mar2023 | ₹472 Cr | 11.30 | |
| Mar2022 | ₹424 Cr | 9.75 | |
| Mar2021 | ₹386 Cr | - | |
Compare Revenue of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,225.7 Cr | 2.9% | 2.1% | 2.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 2.9% |
2.1% |
2.3% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses